AllerBlock Junior— 510(k) K201734

Substantially Equivalent

Nasaleze International, Ltd.

FDA 510(k) clearance K201734 for AllerBlock Junior, Substantially Equivalent on 2021-03-26. Applicant: Nasaleze International, Ltd..

Clearance details

Applicant: Nasaleze International, Ltd.
Product code: Code NUP
Advisory panel: General Hospital
Date received: 2020-06-25
Decision date: 2021-03-26
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Douglas, IM

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.